Relmada Therapeutics, Inc. Common Stock RLMD
$4.59
+0.22%
at last close
Analyst Consensus
- Consensus Rating
- Buy (6 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $12.33
- Implied Upside
- +168.7%
- Price Target Range
- $8.00 – $19.00
- Analysts (12 mo)
- 6
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-06-18 | HC Wainwright & Co.Andres Y. Maldonado |
Initiates coverage on | Buy | $12 |
| 2026-03-24 | Piper SandlerKelsey Goodwin |
Initiates coverage on | Overweight | $12 |
| 2026-03-20 | MizuhoUy Ear |
Maintains | Outperform | $10 → $19 |
| 2026-03-02 | LUCID CAPITAL MARKETSChristopher Liu |
Initiates coverage on | Buy | $14 |
| 2026-01-23 | Leerink PartnersAndrew Berens |
Upgrades | Market perform → Outperform | $8 |
| 2025-12-22 | JefferiesFarzin Haque |
Initiates coverage on | Buy | $9 |
| 2025-11-19 | MizuhoUy Ear |
Upgrades | Neutral → Outperform | $1 → $10 |
| 2024-12-05 | MizuhoUy Ear |
Downgrades | Outperform → Neutral | $23 → $1 |
| 2024-12-04 | Leerink PartnersMarc Goodman |
Downgrades | Outperform → Market perform | $10 → $1 |
| 2024-09-17 | JefferiesAndrew Tsai |
Upgrades | Hold → Buy | $4 → $13 |
| 2024-06-05 | Goldman SachsAndrea Tan |
Downgrades | Neutral → Sell | $3 → $2 |
| 2023-06-15 | MizuhoVamil Divan |
Reiterates | Buy | $26 |
| 2023-01-23 | SVB LeerinkMarc Goodman |
Maintains | Outperform | $42 → $10 |
| 2022-10-14 | Goldman SachsAndrea Tan |
Downgrades | Buy → Neutral | $8 |
| 2022-10-14 | GuggenheimYatin Suneja |
Downgrades | Buy → Neutral | — |
| 2022-10-13 | OppenheimerJay Olson |
Downgrades | Outperform → Perform | — |
| 2022-09-23 | Goldman SachsAndrea Tan |
Maintains | Buy | $49 → $81 |
| 2022-09-06 | GuggenheimYatin Suneja |
Maintains | Buy | $50 → $60 |
| 2022-05-09 | OppenheimerJay Olson |
Maintains | Outperform | $75 → $64 |
| 2022-03-24 | Goldman SachsRoss Weinreb |
Maintains | Buy | $69 → $53 |
| 2021-12-20 | SVB LeerinkMarc Goodman |
Maintains | Outperform | $50 → $42 |
| 2021-11-18 | MizuhoVamil Divan |
Initiates coverage on | Buy | $50 |
| 2020-10-28 | Goldman SachsRoss Weinreb |
Downgrades | Buy → Neutral | $69 → $40 |
| 2020-05-04 | SunTrust Robinson Humphrey |
Initiates coverage on | Buy | $75 |
| 2020-04-21 | Goldman SachsRoss Weinreb |
Initiates coverage on | Buy | $63 |
| 2020-01-27 | JefferiesAndrew Tsai |
Initiates coverage on | Buy | $75 |
| 2019-12-16 | GuggenheimYatin Suneja |
Initiates coverage on | Buy | $64 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $4.59
- Market Cap
- $488.55 million
- 52-Week Range
- $0.55 – $8.00
- Average Volume
- 1.42 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.